AAAAAA

   
Results: 1-11 |
Results: 11
INTRATUMORAL TOREMIFENE THERAPY AND TISSUE DISTRIBUTION IN THE BABOON
Authors: WURZ GT MAENPAA JU HUBBARD GB CADMAN TB SEYMOUR RC SOE L DEGREGORIO MW
Citation: Gt. Wurz et al., INTRATUMORAL TOREMIFENE THERAPY AND TISSUE DISTRIBUTION IN THE BABOON, Anti-cancer drugs, 9(2), 1998, pp. 181-189
PHARMACOKINETIC ANALYSIS OF HIGH-DOSE TOREMIFENE IN COMBINATION WITH DOXORUBICIN
Authors: WURZ GT SOC L EMSHOFF VD CADMAN TB DEGREGORIO MW
Citation: Gt. Wurz et al., PHARMACOKINETIC ANALYSIS OF HIGH-DOSE TOREMIFENE IN COMBINATION WITH DOXORUBICIN, Cancer chemotherapy and pharmacology, 42(5), 1998, pp. 363-366
INTRINSIC REACTIVITY OF TAMOXIFEN AND TOREMIFENE METABOLITES WITH DNA
Authors: HELLMANNBLUMBERG U CARTNER MG WURZ GT DEGREGORIO MW
Citation: U. Hellmannblumberg et al., INTRINSIC REACTIVITY OF TAMOXIFEN AND TOREMIFENE METABOLITES WITH DNA, Breast cancer research and treatment, 50(2), 1998, pp. 135-141
TISSUE DISTRIBUTION OF TRANSDERMAL TOREMIFENE
Authors: SOE L WURZ GT MAENPAA JU HUBBARD GB CADMAN TB WIEBE VJ THEON AP DEGREGORIO MW
Citation: L. Soe et al., TISSUE DISTRIBUTION OF TRANSDERMAL TOREMIFENE, Cancer chemotherapy and pharmacology, 39(6), 1997, pp. 513-520
HALOENOL LACTONE - A NEW SYNERGIST OF CHEMOTHERAPY IN-VITRO
Authors: ZHENG J WURZ GT CADMAN TB DEGREGORIO MW JONES AD HAMMOCK BD
Citation: J. Zheng et al., HALOENOL LACTONE - A NEW SYNERGIST OF CHEMOTHERAPY IN-VITRO, Biochemical and biophysical research communications, 241(1), 1997, pp. 13-17
BREAST-CANCER CHEMOPREVENTION - IS TAMOXIFEN A RATIONAL CHOICE
Authors: MAENPAA J DEGREGORIO MW
Citation: J. Maenpaa et Mw. Degregorio, BREAST-CANCER CHEMOPREVENTION - IS TAMOXIFEN A RATIONAL CHOICE, Annals of medicine, 26(6), 1994, pp. 381-382
FLOW-CYTOMETRY - POTENTIAL UTILITY IN MONITORING DRUG EFFECTS IN BREAST-CANCER
Authors: KOESTER SK MAENPAA JU WIEBE VJ BAKER WJ WURZ GT SEYMOUR RC KOEHLER RE DEGREGORIO MW
Citation: Sk. Koester et al., FLOW-CYTOMETRY - POTENTIAL UTILITY IN MONITORING DRUG EFFECTS IN BREAST-CANCER, Breast cancer research and treatment, 32(1), 1994, pp. 57-65
TAMOXIFEN RESISTANCE IN BREAST-CANCER
Authors: WIEBE VJ OSBORNE CK FUQUA SAW DEGREGORIO MW
Citation: Vj. Wiebe et al., TAMOXIFEN RESISTANCE IN BREAST-CANCER, Critical reviews in oncology/hematology, 14(3), 1993, pp. 173-188
TOREMIFENE ENHANCES CELL-CYCLE BLOCK AND GROWTH-INHIBITION BY VINBLASTINE IN MULTIDRUG-RESISTANT HUMAN BREAST-CANCER CELLS
Authors: BAKER WJ MAENPAA JU WURZ GT KOESTER SK SEYMOUR RC EMSHOFF VD WIEBE VJ DEGREGORIO MW
Citation: Wj. Baker et al., TOREMIFENE ENHANCES CELL-CYCLE BLOCK AND GROWTH-INHIBITION BY VINBLASTINE IN MULTIDRUG-RESISTANT HUMAN BREAST-CANCER CELLS, Oncology research, 5(6-7), 1993, pp. 207-212
A BREAST-CANCER CLONE SELECTED BY TAMOXIFEN HAS INCREASED GROWTH-RATEAND REDUCED SENSITIVITY TO DOXORUBICIN
Authors: MAENPAA JU WURZ GT BAKER WJ WIEBE VJ EMSHOFF VD KOESTER SK SEYMOUR RC KOEHLER RE DEGREGORIO MW
Citation: Ju. Maenpaa et al., A BREAST-CANCER CLONE SELECTED BY TAMOXIFEN HAS INCREASED GROWTH-RATEAND REDUCED SENSITIVITY TO DOXORUBICIN, Oncology research, 5(12), 1993, pp. 461-466
PROLONGED TAMOXIFEN EXPOSURE SELECTS A BREAST-CANCER CELL CLONE THAT IS STABLE IN-VITRO AND IN-VIVO
Authors: SIPILA PEH WIEBE VJ HUBBARD GB KOESTER SK EMSHOFF VD MAENPAA JU WURZ GT SEYMOUR RC DEGREGORIO MW
Citation: Peh. Sipila et al., PROLONGED TAMOXIFEN EXPOSURE SELECTS A BREAST-CANCER CELL CLONE THAT IS STABLE IN-VITRO AND IN-VIVO, European journal of cancer, 29A(15), 1993, pp. 2138-2144
Risultati: 1-11 |